Pharmafile Logo
Pharmafocus logo
Advanced Search

drugs

Showing 15 posts of 771 posts found.

money-2180330_960_720

Forty Seven springs out of the blocks ahead of IPO

June 7, 2018
Research and Development, Sales and Marketing Forty Seven, biotech, drugs, pharma, pharmaceutical

Forty Seven, a spinout from Stanford University, has had a busy few days – first announcing that it had filed …

News
handshake2

Axovant attempts to rise from ashes with $842m Parkinson’s therapy deal

June 7, 2018
Sales and Marketing Axovant, Oxford BioMedica, biotech, drugs, pharma, pharmaceutical

Axovant’s spectacular crash to Earth, after a soaring IPO that saw its share price hit the heady heights of $26, …

News

FlyPharma Conference Europe concludes its fourth successful year in Brussels

June 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, flypharma, pharma, pharmaceutical

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who …

News
diana-bracco-100-01

Milan’s decision to appeal the EMA HQ relocation explained

June 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Milan, biotech, drugs, pharma, pharmaceutical

The decision to award the EMA headquarters to Amsterdam was a contentious one, not least because the vote had to …

Feature
novartis_side_building

Amgen/Novartis migraine med gets CHMP nod

June 4, 2018
Sales and Marketing Aimovig, Amgen, Novartis, biotech, drugs, pharma, pharmaceutical

Amgen and Novartis have announced that their newly FDA-approved treatment for migraines has received a recommendation from the CHMP, generally …

News
doctor_notes

Keytruda offers significant hope in subset of prostate cancer

June 4, 2018
Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, prostate cancer

Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at …

News
onlinr

Celgene bring in new CFO to steady the ship

June 4, 2018
Medical Communications, Sales and Marketing Celgene, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical

The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …

News
bayer_cross_2

Bayer eyes R&D cuts, as Monsanto deal raises question of focus

June 1, 2018
Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical

When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …

News
roche_side_building

Roche resigns itself to failure on SMA drug

June 1, 2018
Medical Communications Roche, biotech, drugs, pharma, pharmaceutical, spinal muscular atrophy

Roche has announced that it will no longer seek to develop its treatment for spinal muscular atrophy (SMA), olesoxime, after …

News
online

Novartis’ US Oncology head makes leap to become biotech CEO

June 1, 2018
Medical Communications Novartis, axcella, biotech, drugs, pharma, pharmaceutical

The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …

News

Staff shortfall leads to massive deficit for NHS

May 31, 2018
Medical Communications NHS, biotech, drugs, pharma, pharmaceutical

The headline figure is that the NHS budget deficit for the year 2017/2018 came in at £960 million, close to …

News
allergan-westport-ireland_web

Allergan aims to appease investors with non-core units sell off

May 31, 2018
Medical Communications Allergan, biotech, drugs, pharma, pharmaceutical

Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …

News
fda_building_web

FDA approval for TherapeuticsMD, one year after initial rejection

May 30, 2018
Sales and Marketing FDA, TherapeuticsMD, biotech, drugs, pharma, pharmaceutical

TherapeuticsMD has succeeded in changing the FDA’s mind on its Imvexxy product, after an initial rejection in May of last …

News
astrazeneca-sign

AZ’s hopes for Fasenra in COPD suffer terminal blow

May 30, 2018
Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical

It looked unlikely that Fasenra would achieve success in the chronic obstructive pulmonary disease (COPD) area, after it suffered in …

News

NHS England uses £10m fund to retain GPs

May 30, 2018
Medical Communications, Research and Development GP, NHS, UK government, biotech, drugs, pharma, pharmaceutical

On the day that news broke, through Pulse, that over a million patients have had to move GP surgery in …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024